Autolus Therapeutics (AUTL) Inventory Average (2025)
Autolus Therapeutics (AUTL) posted quarterly Inventory Average of $30.5 million for Q4 2025, up 17.93% on a QoQ basis from $25.8 million in Q3 2025.
Autolus Therapeutics (AUTL) Inventory Average (2025) Analysis & Trends
Autolus Therapeutics (AUTL) has reported Inventory Average for 1 consecutive years, with $30.5 million the latest figure, recorded in Q4 2025.
- Quarterly Inventory Average changed N/A year-over-year to $30.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $30.5 million (changed N/A YoY) and the FY2025 annual result came in at $18.7 million, changed N/A from the prior year.
- Inventory Average rose to $30.5 million in Q4 2025 per AUTL's latest filing, from $25.8 million in the prior quarter.
- Over the last five years, Inventory Average for AUTL reached as high as $30.5 million in Q4 2025 and fell as low as $9.4 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 644.91 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.15 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Autolus Therapeutics | 404.53 Mn | 103.82 Mn | -1.04 Mn | 30.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 30.47 Mn |
| Sep 30, 2025 | 25.83 Mn |
| Jun 30, 2025 | 19.30 Mn |
| Mar 31, 2025 | 9.39 Mn |